# Addex Therapeutics Ltd.: Form 20-F for the period ended Dec 31, 2024

- Company: [Addex Therapeutics Ltd.](/companies/adxn.md) (CIK 1574232)
- Form: 20-F
- Filed: 2025-05-15
- Accepted by EDGAR: May 15, 2025, 16:01 ET
- Period: 2024-12-31
- Accession: 0001104659-25-049380
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1574232/000110465925049380/adxn-20241231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1574232/000110465925049380/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | CHF 404.1k | ifrs-full:RevenueFromContractsWithCustomers |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | −CHF 2.8m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | CHF 0 | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2024-01-01 to 2024-12-31 | CHF 7.1m | ifrs-full:ProfitLoss |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | CHF 0.07 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | CHF 0.07 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | −CHF 5.4m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | CHF 1.3k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2024-12-31 | CHF 3.3m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2024-12-31 | CHF 3.5m | ifrs-full:CurrentAssets |
| Total assets | at 2024-12-31 | CHF 10.7m | ifrs-full:Assets |
| Current liabilities | at 2024-12-31 | CHF 802.1k | ifrs-full:CurrentLiabilities |
| Shareholders' equity | at 2024-12-31 | CHF 9.7m | ifrs-full:Equity |
| Shares outstanding | at 2024-12-31 | 128,292,969 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1574232/000110465925049380/adxn-20241231x20f.htm

Filed May 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-049380. Last ingested by Listed: Nov 14, 2026, 18:51 ET. No prices; not investment advice.
